Dendritic cells and TNF-Related apoptosis inducing ligand (TRAIL) represent new possibilities for sepsis treatment
Open Access
- 14 November 2017
- journal article
- Published by Heighten Science Publications Corporation in Insights in Clinical and Cellular Immunology
- Vol. 1 (1), 001-004
- https://doi.org/10.29328/journal.hcci.1001001
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Immunosuppression in Patients Who Die of Sepsis and Multiple Organ FailureJAMA, 2011
- Multiplex cytokine profiling in patients with sepsisAPMIS, 2010
- Mortality in human sepsis is associated with downregulation of Toll-like receptor 2 and CD14 expression on blood monocytesDiagnostic Pathology, 2009
- Bench-to-bedside review: Mitochondrial injury, oxidative stress and apoptosis – there is nothing more practical than a good theoryCritical Care, 2008
- Historical insights into cytokinesEuropean Journal of Immunology, 2007
- Cytokine profiles as markers of disease severity in sepsis: a multiplex analysisCritical Care, 2007
- Severe Sepsis Exacerbates Cell-Mediated Immunity in the Lung Due to an Altered Dendritic Cell Cytokine ProfileThe American Journal of Pathology, 2006
- Dendritic cells during polymicrobial sepsis rapidly mature but fail to initiate a protective Th1-type immune responseJournal of Leukocyte Biology, 2005
- Identification of a New Murine Tumor Necrosis Factor Receptor Locus That Contains Two Novel Murine Receptors for Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)Online Journal of Public Health Informatics, 2003
- Pro‐ versus Anti‐inflammatory Cytokine Profile in Patients with Severe Sepsis: A Marker for Prognosis and Future Therapeutic OptionsThe Journal of Infectious Diseases, 2000